Histone deacetylases and cancer

被引：391

作者：

Barneda-Zahonero, Bruna ^{[1
]}

Parra, Maribel ^{[1
]}

机构：

[1] Bellvitge Biomed Res Inst IDIBELL, Cellular Differentiat Grp, Canc Epigenet & Biol Program PEBC, Barcelona 08908, Spain

来源：

MOLECULAR ONCOLOGY | 2012年 / 6卷 / 06期

关键词：

Protein acetylation; Histone deacetylases; Cancer; HUMAN BREAST-CANCER; CLASS-II; DIFFERENTIAL EXPRESSION; GENE-EXPRESSION; HEPATOCELLULAR-CARCINOMA; PRECLINICAL ACTIVITY; CELL-PROLIFERATION; DOWN-REGULATION; HDAC INHIBITOR; POOR-PROGNOSIS;

D O I：

10.1016/j.molonc.2012.07.003

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Reversible acetylation of histone and non-histone proteins is one of the most abundant post-translational modifications in eukaryotic cells. Protein acetylation and deacetylation are achieved by the antagonistic actions of two families of enzymes, histone acetyltransferases (HATs) and histone deacetylases (HDACs). Aberrant protein acetylation, particularly on histones, has been related to cancer while abnormal expression of HDACs has been found in a broad range of cancer types. Therefore, HDACs have emerged as promising targets in cancer therapeutics, and the development of HDAC inhibitors (HDIs), a rapidly evolving area of clinical research. However, the contributions of specific HDACs to a given cancer type remain incompletely understood. The aim of this review is to summarize the current knowledge concerning the role of HDACs in cancer with special emphasis on what we have learned from the analysis of patient samples. (c) 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

引用

页码：579 / 589

页数：11

共 118 条

[1] Class I histone deacetylases 1, 2 and 3 are highly expressed in classical Hodgkin's lymphoma [J].

Adams, Heiner ;

Fritzsche, Florian R. ;

Dirnhofer, Stephan ;

Kristiansen, Glen ;

Tzankov, Alexandar .

EXPERT OPINION ON THERAPEUTIC TARGETS, 2010, 14 (06) :577-584

[2] Tubacin suppresses proliferation and induces apoptosis of acute lymphoblastic leukemia cells [J].

Aldana-Masangkay, Grace I. ;

Rodriguez-Gonzalez, Agustin ;

Lin, Tara ;

Ikeda, Alan K. ;

Hsieh, Yao-Te ;

Kim, Yong-Mi ;

Lomenick, Brett ;

Okemoto, Kazuo ;

Landaw, Elliot M. ;

Wang, Dongpeng ;

Mazitschek, Ralph ;

Bradner, James E. ;

Sakamoto, Kathleen M. .

LEUKEMIA & LYMPHOMA, 2011, 52 (08) :1544-1555

[3] ACETYLATION + METHYLATION OF HISTONES + THEIR POSSIBLE ROLE IN REGULATION OF RNA SYNTHESIS [J].

ALLFREY, VG ;

FAULKNER, R ;

MIRSKY, AE .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1964, 51 (05) :786-+

[4] ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain [J].

Amann, JM ;

Nip, J ;

Strom, DK ;

Lutterbach, B ;

Harada, H ;

Lenny, N ;

Downing, JR ;

Meyers, S ;

Hiebert, SW .

MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (19) :6470-6483

[5] Altered sirtuin expression is associated with node-positive breast cancer [J].

Ashraf, N. ;

Zino, S. ;

MacIntyre, A. ;

Kingsmore, D. ;

Payne, A. P. ;

George, W. D. ;

Shiels, P. G. .

BRITISH JOURNAL OF CANCER, 2006, 95 (08) :1056-1061

[6] Histone deacetylase 3 (HDAC3) is recruited to target promoters by PML-RARα as a component of the N-CoR co-repressor complex to repress transcription in vivo [J].

Atsumi, Akihide ;

Tomita, Akihiro ;

Kiyoi, Hitoshi ;

Naoe, Tomoki .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 345 (04) :1471-1480

[7] A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas [J].

Balasubramanian, S. ;

Ramos, J. ;

Luo, W. ;

Sirisawad, M. ;

Verner, E. ;

Buggy, J. J. .

LEUKEMIA, 2008, 22 (05) :1026-1034

[8] Regulation of chromatin by histone modifications [J].

Bannister, Andrew J. ;

Kouzarides, Tony .

CELL RESEARCH, 2011, 21 (03) :381-395

[9] SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation [J].

Barber, Matthew F. ;

Michishita-Kioi, Eriko ;

Xi, Yuanxin ;

Tasselli, Luisa ;

Kioi, Mitomu ;

Moqtaderi, Zarmik ;

Tennen, Ruth I. ;

Paredes, Silvana ;

Young, Nicolas L. ;

Chen, Kaifu ;

Struhl, Kevin ;

Garcia, Benjamin A. ;

Gozani, Or ;

Li, Wei ;

Chua, Katrin F. .

NATURE, 2012, 487 (7405) :114-+

[10] SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production [J].

Bell, E. L. ;

Emerling, B. M. ;

Ricoult, S. J. H. ;

Guarente, L. .

ONCOGENE, 2011, 30 (26) :2986-2996

← 1 2 3 4 5 6 7 8 9 10 →